Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Future Oncology (London, England)
|
October 19, 2020
The future of colorectal cancer research: an interview with Hans Schmoll
Hans-Joachim Schmoll
Anti-Cancer Drugs
|
October 11, 2003
Dihydropyrimidine dehydrogenase inhibition as a strategy for the oral administration of 5-fluorouracil: utility in the treatment of advanced colorectal cancer
Hans-Joachim Schmoll
Therapeutic Advances in Medical Oncology
|
May 2, 2013
Systemic treatment of liver metastases from colorectal cancer
Alexander Stein, Hans-Joachim Schmoll
The Oncologist
|
October 13, 2006
Update on capecitabine in colorectal cancer
Hans-Joachim Schmoll, Dirk Arnold
Oncology
|
November 23, 2005
The future development of bevacizumab in colorectal cancer
Eduardo Díaz-Rubio, Hans-Joachim Schmoll
Gastrointestinal Cancer Research : GCR
|
April 9, 2009
Accomplishments in 2007 in the management of advanced gastroesophageal cancer
Jaffer A Ajani, Hans-Joachim Schmoll
Drugs
|
November 17, 2011
Adjuvant therapy for early colon cancer: current status
Alexander Stein, Sonja Hiemer, Hans-Joachim Schmoll
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2005
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment
Karin Jordan, Christoph Kasper, Hans-Joachim Schmoll
The Oncologist
|
October 5, 2007
Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations
Karin Jordan, Christoph Sippel, Hans-Joachim Schmoll
Medizinische Klinik (Munich, Germany : 1983)
|
June 25, 2002
[Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms]
Axel Grothey, Lenka Kellermann, Hans-Joachim Schmoll
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Future Oncology (London, England)
|
October 19, 2020
The future of colorectal cancer research: an interview with Hans Schmoll
Hans-Joachim Schmoll
Anti-Cancer Drugs
|
October 11, 2003
Dihydropyrimidine dehydrogenase inhibition as a strategy for the oral administration of 5-fluorouracil: utility in the treatment of advanced colorectal cancer
Hans-Joachim Schmoll
Therapeutic Advances in Medical Oncology
|
May 2, 2013
Systemic treatment of liver metastases from colorectal cancer
Alexander Stein, Hans-Joachim Schmoll
The Oncologist
|
October 13, 2006
Update on capecitabine in colorectal cancer
Hans-Joachim Schmoll, Dirk Arnold
Oncology
|
November 23, 2005
The future development of bevacizumab in colorectal cancer
Eduardo Díaz-Rubio, Hans-Joachim Schmoll
Gastrointestinal Cancer Research : GCR
|
April 9, 2009
Accomplishments in 2007 in the management of advanced gastroesophageal cancer
Jaffer A Ajani, Hans-Joachim Schmoll
Drugs
|
November 17, 2011
Adjuvant therapy for early colon cancer: current status
Alexander Stein, Sonja Hiemer, Hans-Joachim Schmoll
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2005
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment
Karin Jordan, Christoph Kasper, Hans-Joachim Schmoll
The Oncologist
|
October 5, 2007
Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations
Karin Jordan, Christoph Sippel, Hans-Joachim Schmoll
Medizinische Klinik (Munich, Germany : 1983)
|
June 25, 2002
[Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms]
Axel Grothey, Lenka Kellermann, Hans-Joachim Schmoll
Page
of 12